Tag: Pfizer’s Chairman and CEO Dr. Albert Bourla

  • This is Why Shares of Pfizer Could Race Higher

    This is Why Shares of Pfizer Could Race Higher

    Pfizer is pushing to higher highs. After finding support around $41, the vaccine stock bolted to nearly $46, and could test $47, even $50, near-term.  All after the company raised its full-year sales forecast to $36 billion, as it signed deals for booster doses.  The stock could push even higher on a US CDC vote.…